Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Texas Publishes 2024 Insurance Carrier Performance Results

Approximately 44 carriers were high performers, 82 were average, and 4 were ranked poorly.
Read More →
October 28, 2024

New York Issues Guidance on Cybersecurity Risks from AI

AI-enabled social engineering and AI-enhanced cybersecurity attacks are some of the many topics addressed in the guidance.
Read More →
October 28, 2024

Nevada Revises Rules on Provider Lists and Forms

Starting October 1, 2025, provider lists must be submitted through the Division’s CARDS system, set to launch next spring.
Read More →
October 28, 2024

Minnesota Invites Public to Complete PTSD Survey to Identify Needed Changes

The survey takes 10-15 minutes to complete, and some respondents may be asked for follow-up interviews. All responses will remain anonymous.
Read More →
October 28, 2024

CWCI Publishes Opioid Prescribing Report for Injured Workers

Between 2017-2023, opioid prescribing fell 34%, from 6.8 million members of the general population (17.3%) to 4.5 million (11.5%).
Read More →
October 28, 2024

McKinsey Close to Settling U.S. Opioid Investigations

A payment of over $500 million could soon be made to resolve federal investigations tied to the opioid epidemic.
Read More →
October 21, 2024

NCCI Publishes New Labor Market Insights Report

September saw the addition of 254,000 new jobs, with much of the growth in healthcare, leisure and hospitality, and construction.
Read More →
October 21, 2024

WCRI Publishes 25th Edition of CompScope Medical Benchmarks

The reports analyze trends in payments, prices, and medical care utilization across 17 states from 2017-2022.
Read More →
October 21, 2024

California P&T Meeting Reviews Pharmacy Fee Schedule and Formulary Updates

Public comments for the proposed changes to the fee schedule will be accepted until October 23rd.
Read More →
October 21, 2024
1 39 40 41 42 43 46

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Marijuana Bills Could Create Protections for Employment Discrimination

Testing positive for marijuana use could one day no longer prohibit employment.
Read More

An Opioid Snapshot for 2020

With a flurry of opioid developments lately, what does the big picture look like?
Read More

Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.
Read More

Psilocybin for Mental Health Disorders?

Does the active ingredient in magic mushrooms have a future in mental health?
Read More

MDMA Gains Steam for PTSD Treatment

Phase 3 studies are underway, and current research sees potential for MDMA in psychotherapy.
Read More

Lavender Administration Shows Promise for Anxiety

A recent meta-analysis of over 100 trials and studies found lavender to significantly reduce anxiety levels.
Read More
1 39 40 41 42 43 49
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle